Northwestern Mutual Wealth Management
ALXN

Northwestern Mutual Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,719
Closed -$500K – 3345
2021
Q2 		$500K Sell
2,719
-484
-15% -$83.1K ﹤0.01% 982
2021
Q1 		$490K Sell
3,203
-553
-15% -$85.5K ﹤0.01% 929
2020
Q4 		$587K Buy
3,756
+159
+4% +$20.4K ﹤0.01% 788
2020
Q3 		$412K Buy
3,597
+218
+6% +$23.5K ﹤0.01% 804
2020
Q2 		$380K Buy
3,379
+818
+32% +$86.8K ﹤0.01% 774
2020
Q1 		$229K Buy
2,561
+361
+16% +$35.4K ﹤0.01% 841
2019
Q4 		$237K Sell
2,200
-191
-8% -$20.4K ﹤0.01% 887
2019
Q3 		$234K Sell
2,391
-1,225
-34% -$138K ﹤0.01% 836
2019
Q2 		$474K Buy
3,616
+417
+13% +$53.7K ﹤0.01% 642
2019
Q1 		$432K Buy
3,199
+214
+7% +$26.6K ﹤0.01% 665
2018
Q4 		$291K Sell
2,985
-239
-7% -$28.3K ﹤0.01% 698
2018
Q3 		$448K Buy
3,224
+109
+3% +$13.7K ﹤0.01% 591
2018
Q2 		$386K Sell
3,115
-97
-3% -$11.3K ﹤0.01% 595
2018
Q1 		$358K Buy
3,212
+332
+12% +$39.7K ﹤0.01% 585
2017
Q4 		$344K Sell
2,880
-442
-13% -$53.8K ﹤0.01% 587
2017
Q3 		$467K Sell
3,322
-182
-5% -$24.7K ﹤0.01% 496
2017
Q2 		$426K Buy
3,504
+277
+9% +$32.2K ﹤0.01% 510
2017
Q1 		$391K Sell
3,227
-970
-23% -$125K ﹤0.01% 506
2016
Q4 		$514K Buy
+4,197
New +$514K 0.01% 448
2016
Q3 		– Sell
-3,483
Closed -$407K – 1721
2016
Q2 		$407K Sell
3,483
-128
-4% -$18.2K 0.01% 443
2016
Q1 		$503K Buy
3,611
+1,321
+58% +$194K 0.01% 388
2015
Q4 		$437K Sell
2,290
-171
-7% -$29.9K 0.01% 370
2015
Q3 		$385K Sell
2,461
-163
-6% -$29.7K 0.01% 376
2015
Q2 		$475K Sell
2,624
-7
-0.3% -$1.21K 0.01% 331
2015
Q1 		$456K Buy
2,631
+437
+20% +$79.1K 0.01% 332
2014
Q4 		$406K Buy
2,194
+276
+14% +$51.1K 0.01% 327
2014
Q3 		$318K Sell
1,918
-173
-8% -$28.4K 0.01% 347
2014
Q2 		$327K Buy
2,091
+151
+8% +$23.8K 0.01% 323
2014
Q1 		$295K Buy
1,940
+83
+4% +$13.2K 0.01% 334
2013
Q4 		$246K Buy
1,857
+11
+0.6% +$1.32K 0.01% 353
2013
Q3 		$215K Buy
1,846
+192
+12% +$21.1K 0.01% 342
2013
Q2 		$153K Buy
+1,654
New +$159K 0.01% 375

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return